Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Bay City Capital LLC is a life sciences investment firm founded in 1997 and headquartered in the San Francisco Bay Area. The firm has established itself as one of the longest-running dedicated life sciences venture capital firms on the West Coast. Bay City Capital manages five venture capital funds, boasting total capital commitments of $1.3 billion. Over its history, the firm has invested in more than 100 companies worldwide, demonstrating a strong commitment to fostering innovation and growth in the life sciences sector.
The firm has a diverse portfolio that spans various life sciences sectors, including biopharmaceuticals, medical devices, diagnostics, healthcare IT, nutrition, and agribusiness. Bay City Capital's notable milestones include successful exits such as Nevro, Dermira, and Map Pharmaceuticals, showcasing its ability to identify and support high-potential companies. The firm operates from its office in San Rafael, California, and continues to expand its influence in the global life sciences market.
Bay City Capital focuses on investing in life sciences companies across a wide range of sectors, including biotech, healthcare, medical devices, health platforms, diagnostics, and pharma-tech. The firm invests at various stages of company development, from seed stage to Series C and IPO. This broad investment strategy allows Bay City Capital to engage with companies at different points in their growth trajectories, providing the necessary capital and support to drive innovation.
Investment checks typically range from seed funding to larger growth equity rounds, reflecting the firm's commitment to supporting companies as they scale. Bay City Capital emphasizes innovation and restructuring opportunities, seeking to partner with founders who demonstrate a clear vision and the potential for significant impact in their respective fields. The firm’s investment thesis centers on identifying and nurturing companies that are poised for growth and can benefit from strategic guidance and industry expertise.
Bay City Capital has built a diverse portfolio of over 100 companies, showcasing its extensive reach within the life sciences sector. Notable portfolio companies include:
This portfolio reflects Bay City Capital's strategic focus on innovative life sciences companies that have the potential to make significant contributions to healthcare and medical technology.
Fred Craves, PhD - Managing Director. Fred has extensive experience in the life sciences sector and has led numerous successful investments.
David Beier, JD - Managing Director. David brings a strong legal background and has been involved in various high-profile deals in the biotech space.
Matthew Kronmiller - Professional Staff. Matthew supports the investment team with research and analysis.
Susan Vuong - Professional Staff. Susan assists in portfolio management and operational support for portfolio companies.
Larry Clay - Professional Staff. Larry contributes to the firm's investment strategy and analysis.
Carl Goldfischer, MD - Advisor. Carl provides medical expertise and insights into healthcare investments.
Lionel Carnot, MS, MBA - Advisor. Lionel offers strategic guidance and industry connections to portfolio companies.
Manuel Lopez-Figueroa, PhD - Advisor. Manuel brings scientific expertise and helps evaluate potential investments in biotech.
Founders interested in pitching to Bay City Capital should submit their proposals through the firm's website at baycitycapital.com. The pitch deck should include essential information such as the business model, market analysis, and team qualifications. Response times may vary, but founders can expect to hear back within a few weeks. Warm introductions are preferred, as they can facilitate a more favorable review process.
In recent months, Bay City Capital has continued to expand its portfolio, maintaining an active presence in the life sciences sector. The firm has made several investments in innovative companies, although specific details on recent deals have not been disclosed. Notable past exits include Nevro, Dermira, and Map Pharmaceuticals, which highlight the firm's successful track record in identifying high-potential investments.
Bay City Capital's commitment to supporting life sciences innovation remains strong, as evidenced by its ongoing investments and strategic guidance provided to portfolio companies. The firm continues to seek out opportunities that align with its focus on growth and restructuring in the life sciences sector.
What are Bay City Capital's investment criteria?
Bay City Capital invests in life sciences companies across various sectors, including biotech, medical devices, and diagnostics. The firm looks for innovative solutions and strong management teams capable of driving growth.
How can founders pitch to Bay City Capital?
Founders can pitch their ideas through the firm's website at baycitycapital.com. A well-prepared pitch deck should include details about the business model, market opportunity, and team qualifications.
What makes Bay City Capital different from other VCs?
Bay City Capital has a long history in the life sciences sector, with a focus on growth and restructuring opportunities. The firm provides strategic guidance and leverages its extensive network to support portfolio companies.
What is the geographic scope of Bay City Capital's investments?
The firm invests globally, with a particular emphasis on North America. This broad geographic focus allows Bay City Capital to tap into diverse markets and opportunities.
What is the typical check size for investments?
Bay City Capital invests at various stages, with check sizes ranging from seed funding to larger growth equity rounds, depending on the company's needs and stage of development.
What kind of post-investment involvement does Bay City Capital have?
The firm actively engages with its portfolio companies, providing strategic guidance, operational support, and access to its extensive network to help drive growth and innovation.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.